Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Nov 14, 2019 (7 years ago)

Yeast Arrest

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

cGMP violations

Cause type: cGMP deviation

Departures from current Good Manufacturing Practice found in production or during FDA inspection. A broad quality-system cause: the batch was made under conditions that fall short of FDA manufacturing standards. All cgmp deviation recalls.

What was recalled

Yeast Arrest, Homeopathic Formula, Vaginal Support suppositories, packaged in a) 14-count carton (NDC 68093-0730-1 and 68093-0730-3), b) 28-count carton (NDC 68093-0730-2 and 68093-0730-4), Manufactured for: Vitanica, 12401 SW Leveton Drive, Tualatin, OR 97062.

Affected NDCs 68093-0730-01 68093-0730-02 68093-0730-03 68093-0730-04

Compare with the code on your package — it is the most precise check available.

Recalling firm
Wisconsin Pharmacal Company, LLC
NDC code
68093-0730-1
Origin
WI, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0781-2020 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other recalls by Wisconsin Pharmacal Company, LLC

All 2019 recalls
Class II · Moderate risk

CVS pharmacy

Microbial Contamination of Non-Sterile Products: CVS Pharmacy Pain Relieving Antiseptic Spray tested positive for microbial growth.

Terminated Microbial contamination Wisconsin Pharmacal Company NDC 68093-6150-1 D-0047-2015

Other cgmp deviation recalls from 2019

All cgmp deviation recalls